HLADQA1*05 Genotype and the Efficacy of Treatment With Infliximab in Chinese Population Crohn's Disease

NCT05813860 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

976

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease
Infliximab

Interventions

DRUG: Azathioprine
DRUG: Infliximab

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University